Understanding Stem Cell Research for Macular Degeneration

Stem cell research is offering new possibilities for treating age-related macular degeneration (AMD), a leading cause of vision loss. In this Macular Chat, Dr. Jeffrey Stern and Dr. Sally Temple, Principal Investigators and Co-Founders of the Neural Stem Cell Institute, will explain what stem cells are, share the latest updates from clinical trials such as Luxa Biotechnology’s RPESC-RPE transplantation, and discuss the safety, outcomes, and future potential of stem cell therapies. They will also address what these advances mean for patients and caregivers today, what clinical trials are available, and what timelines might look like for making these treatments more widely accessible.